Public-registry site landscape for NCT04620590, a Diabetes Mellitus, Type 2 study sponsored by Emerald Clinical Inc.. All data below is from public sources; Eichor is not affiliated with the sponsor.
| Trial | NCT04620590 (registry record) |
| Sponsor | Emerald Clinical Inc. |
| Condition(s) | Diabetes Mellitus, Type 2; Impaired Renal Function |
| Phase | PHASE4 |
| Listed sites | 2 |
| Site countries | United States, Canada |
Eichor generates a preliminary site-risk snapshot for NCT04620590 — how the roster screens on competing-trial load, enrollment track record, and PI–indication fit — free, usually same day. Request it here →